Revanasiddappa B C

Dr. Revanasiddappa B C


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MSMahendra Gowdru Srinivasa
Mahendra Gowdru Srinivasa
RCRevanasiddappa B C
Revanasiddappa B C
APAshwini Prabhu
Ashwini Prabhu
VRVinitha Rani
Vinitha Rani
SGSudeep D. Ghate
Sudeep D. Ghate
PRPrashantha B R
Prashantha B R
The present study was conducted to develop new novel 2,4-thiazolidinedione derivatives (3h–3j) as peroxisome proliferator-activated receptor-γ (PPAR-γ) modulators for antidiabetic activity. The objective was to overcome the adverse effects of existing thiazolidinediones while maintaining their pharmacological benefits. The synthesized compounds were elucidated based on FT-IR, 1H-NMR, 13C-NMR, and MS techniques. Molecular docking was utilized to investigate the interaction binding modes, binding free energy, and amino acids engaged in the compounds' interactions with the target protein. Subsequently, molecular dynamics modelling was used to assess the stability of the top-docked complexes and an assay was utilized to assess the cytotoxicity of the compounds to C2C12 myoblasts. Compounds 3h–3j exhibited PPAR-γ modulatory activity and demonstrated significant hypoglycaemic effects when compared to the reference drug pioglitazone. The new compounds were evaluated for their in vivo blood glucose-lowering potential by using a dexamethasone-induced diabetic rat model. All the compounds showed a hypoglycaemic effect of 108.04 ± 4.39, 112.55 ± 6.10, and 117.48 ± 43.93, respectively, along with pioglitazone (153.93 ± 4.61) compared to the diabetic control. Additionally, all the compounds significantly reduced AST and ALT levels and did not cause liver damage.

21 April 2022 in Journal of Molecular Recognition
Verified
Journal Article
Closed access
MSMahendra Gowdru Srinivasa
Mahendra Gowdru Srinivasa
NANatasha Naval Aggarwal
Natasha Naval Aggarwal
BGBanylla Felicity Dkhar Gatpoh
Banylla Felicity Dkhar Gatpoh
MSMadan Kumar Shankar
Madan Kumar Shankar
KRKannika Byadarahalli Ravindranath
Kannika Byadarahalli Ravindranath
RCRevanasiddappa B C
Revanasiddappa B C

7 December 2021 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Open access
PDF file
UYUndiganalu Gangadharappa Yathisha
Undiganalu Gangadharappa Yathisha
MSMahendra Gowdru Srinivasa
Mahendra Gowdru Srinivasa
RCRevanasiddappa B C
Revanasiddappa B C
SMSubankar P Mandal
Subankar P Mandal
DDDr. Sheshagiri Ravindra Dixit
Dr. Sheshagiri Ravindra Dixit
MBMamatha BS
Mamatha BS
Recently, multi-functional fish peptides (FWPs) have gained a lot of attention because of their different biological activities. In the present study, three Angiotensin-I Converting Enzyme (ACE-I) inhibitory peptides [Ala-Pro-Asp-Gly (APDG), Pro-Thr-Arg (PTR), and Ala-Asp (AD)] were isolated and characterized from ribbonfish protein hydrolysate (RFPH) and described their mechanism of action on ACE activity. As per the results peptide PTR showed ≈ 2 and 2.5-fold higher enzyme inhibitory activity (IC50 = 0.643 ± 0.0011 μM) than APDG (IC50 = 1.061 ± 0.0127 μM) and AD (IC50= 2.046 ± 0.0130 μM). Based on experimental evidence, peptides were used for in silico analysis to check the inhibitory activity of the main protease (PDB: 7BQY) of SARS-CoV-2. The results of the study reveal that PTR (−46.16 Kcal/mol) showed higher binding affinity than APDG (−36.80 Kcal/mol) and AD (−30.24 Kcal/mol) compared to Remdesivir (−30.64 Kcal/mol). Additionally, physicochemical characteristics of all the isolated peptides exhibited appropriate pharmacological properties and were found to be nontoxic. Besides, 20 ns molecular dynamic simulation study confirms the rigid nature, fewer confirmation variations and binding stiffness of the peptide PTR with the main protease of SARS-CoV-2. Therefore, the present study strongly suggested that PTR is the perfect substrate for inhibiting the main protease of SARS-CoV-2 through the in-silico study, and this potential drug candidate may promote the researcher for future wet-lab experiments.

7 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SPSharmila Kameyanda Poonacha
Sharmila Kameyanda Poonacha
Harishkumar MadhyasthaHarishkumar Madhyastha
Harishkumar Madhyastha
MRMadhyastha Radha
Madhyastha Radha
RVRemya Varadarajan
Remya Varadarajan
SKSuchetha Kumari
Suchetha Kumari
SBsatheesh Kumar Bhandary
satheesh Kumar Bhandary
Oroxylum indicum, of the Bignoniaceae family, has various ethnomedical uses such as an astringent, anti-inflammatory, anti-bronchitis, anti-helminthic and anti-microbial, including anticancer properties. The druggability of OI stem bark extract was determined by its molecular docking interactions with PARP and Caspase-3, two proteins involved in cell survival and death. Note that 50 µg/mL of Oroxylum indicum extract (OIE) showed a significant (p < 0.05%) toxicity to HSC-3 cells. MTT aided cell viability and proliferation assay demonstrated that 50 µg/mL of OIE displayed significant (p < 0.5%) reduction in cell number at 4 h of incubation time. Cell elongation and spindle formation was noticed when HSC-3 cells were treated with 50 µg/mL of OIE. OIE initiated DNA breakage and apoptosis in HSC-3 cells, as evident from DNA ladder assay and calcein/EB staining. Apoptosis potential of OIE is confirmed by flow cytometer and triple-staining (live cell/apoptosis/necrosis) assay. Caspase-3/7 fluorescence quenching (LANCE) assay demonstrated that 50 µg/mL of OIE significantly enhanced the RFU of caspases-3/7, indicating that the apoptosis potential of OIE is probably through the activation of caspases. Immuno-cytochemistry of HSC-3 cells treated with 50 µg/mL of OIE showed a significant reduction in mitochondrial bodies as well as a reduction in RFU in 60 min of incubation time. Immunoblotting studies clearly showed that treatment of HSC-3 cells with OI extract caused caspase-3 activation and PARP deactivation, resulting in apoptotic cell death. Overall, our data indicate that OIE is an effective apoptotic agent for human squamous carcinoma cells and it could be a future cancer chemotherapeutic target.

10 November 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SNShridhar Deshpande N.
Shridhar Deshpande N.
PDPrarambh S R Dwivedi
Prarambh S R Dwivedi
RCRevanasiddappa B C
Revanasiddappa B C
F. carica is a small tree and commonly used as a traditional medicine against several disorders. Diabetes is currently treated with insulin and oral hypoglycemic medicines such as sulphonyl urea derivatives, bigunides, thiazolidinediones and alpha-glucosidase inhibitors. Peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists were found to be very much beneficial in the management of diabetes by inhibiting hepatic gluconeogenesis. The aim of this study is to evaluate the bioactive phytoconstituents from Ficus carica Linn. against the target PPAR-γ agonist by in silico docking approach. We investigated 68 phytoconstituents as potential inhibitors of PPAR-γ agonists and the top 24 phytoconstituents were further selected for molecular docking studies. Drug ability, side effects, and ADMET analysis were determined by using MolSoft, toxtree freeware, and ADMET SAR web server, respectively. The phytoconstituents were docked with the target PPAR-γ (PDB ID: 4Y29, 1.98 Å) receptor. Quercetin-3-o-rutinoside possessed the highest G score -14.22 kcal/mol, followed by Angelicin with a G score of -13.56 kcal/mol. All the other phytoconstituents displayed good pharmacokinetic and toxicological parameters with values within the permissible limits. The ligand-protein interaction was calculated by molecular dynamic (MD) simulation study. Subsequently, the binding free energy of the Quercetin-3-o-rutinosideand Pioglitazone complex was calculated using MMPBSA analysis. The results indicated that some of the phytoconstituents from Ficus carica have potency as an anti-diabetic agents. So, these bioactive phytoconstituents like Quercetin-3-o-glucoside, 5-O-caffeoylquinic acids may act as a good agonist for PPAR-γ.Communicated by Ramaswamy H. Sarma.

5 September 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
DPDinesha P
Dinesha P
SNShivakumar Naik
Shivakumar Naik
UDUdaya Kumar D
Udaya Kumar D
RCRevanasiddappa B C
Revanasiddappa B C
VRVenkatesh Ranjan
Venkatesh Ranjan
NVNaveena S. Veeranagaiah
Naveena S. Veeranagaiah
A new set of imidazo[1,2-a]pyrimidine-thiazole hybrids were developed through a molecular hybridization concept. Three compounds exhibited potent anti-TB activity with MIC of 1.6 μg mL−1.